BEST of ASCO Portugal 2024 - HN
Abstract
In June 2024, at the annual meeting of the American Society of Clinical Oncology (ASCO), relevant data in the area of metastatic breast cancer were presented in Chicago (USA). The results with the greatest impact on clinical practice are presented below.
Downloads
References
Gradishar WJ et al, J Natl Compr Canc Netw 2023;21(6):594–608
Sledge et al, JAMA Oncol. 2020;6(1):116-124.
Kalinsky K et al, J Clin Oncol. 2023 Aug 20;41(24):4004-4013.
Mayer EL et al, J Clin Oncol. 2024 Jun 10;42(17):2050-2060
Llombart-Cussac A et al, J Clin Oncol 41, 2023 (suppl 16; abstr 1001)
Juric D et al, Cancer Res (2019) 79 (4_Supplement): GS3-08
Turner NC et al, N Engl J Med 2023;388:2058-2070
Bidard FC et al, J Clin Oncol. 2022 Oct 1;40(28):3246-3256.
Hong R et al, Cancer Res (2018) 78 (4_Supplement): PD4-14.
Herrera-Abreu MT et al, Cancer Res. 2016 Apr 15;76(8):2301-13
Vora SR et al, Cancer Cell. 2014 Jul 14;26(1):136-49
Song KW et al, Cancer Discov. 2022 Jan;12(1):204-219
Tung et al, J Clin Oncol 2020 Dec 20;38(36):4274-4282
Wolff AC et al, J Clin Oncol. 2023 Aug 1;41(22):3867-3872
Denkert C et al, Lancet Oncol. 2021 Aug;22(8):1151-1161
Chen Z et al, Breast Cancer Res Treat. 2023 Nov;202(2):313-323
O'Shaughnessy J et al, JAMA Netw Open. 2021;4(4):e214103
O'Shaughnessy J et al, Cancer Res (2021) 81 (4_Supplement): GS4-01
Robert NJ et al, J Clin Oncol. 2011 Apr 1;29(10):1252-60
